Back to Search Start Over

Differences and potential mechanisms of theta oscillation and temporoparietal and temporal-central networks in temporal lobe epilepsy patients with unilateral hippocampal sclerosis.

Authors :
Qiu, Chenxi
Zhong, Chenxi
Liu, Ying
Wang, Liju
Tang, Yingying
Liu, Zhiyi
Guo, Sijia
Jiang, Yingqi
Li, Enzhi
Lu, Jing
Yan, Bo
Hao, Xiaoting
Zhou, Dong
Source :
Acta Epileptologica; 8/25/2024, Vol. 6 Issue 1, p1-11, 11p
Publication Year :
2024

Abstract

Background: There is a lack of further exploration of the epileptogenic network of specific types of epilepsy, such as unilateral hippocampal sclerosis (HS), and there is an urgent need to find exact evidence to confirm the consistency of its brain network changes. Methods: We enrolled 22 mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE-HS) patients to compare the differences in brain activity between 22 healthy controls (HCs) and them. Resting-state electroencephalography (EEG) was also measured. Then, we calculated the power spectral density and phase locking values in and between these electrodes. Results: The results showed the increased theta power was related to the high severity of epilepsy in the temporal, parietal, and central regions in mTLE-HS patients, and there were positive correlations between theta power in the contralateral temporal region and seizure frequency. Theta power in the ipsilateral parietal lobe is positively correlated with the number of anti-seizure medications (ASMs), but not with the usage of third-generation ASMs. Meanwhile, the temporal lobe of mTLE-HS patients had more connectivity with parietal lobe and central region. Conclusions: Theta power is an important EEG indicator of mTLE-HS, positively correlates with epilepsy severity and seizure frequency, and has network properties that can be observed outside the lesion. Moreover, the usage of third-generation ASMs did not affect the risk of increased theta power. Lastly, the temporoparietal and temporal-central networks are likely to be causative pathways in epilepsy patients with cognitive impairment. This study provides a potential guideline for the treatment of mTLE-HS in clinical practice. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20969384
Volume :
6
Issue :
1
Database :
Complementary Index
Journal :
Acta Epileptologica
Publication Type :
Academic Journal
Accession number :
179234484
Full Text :
https://doi.org/10.1186/s42494-024-00170-7